HomeOMIC • NASDAQ
Singular Genomics Systems Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 406.00K | -12.12% |
Operating expense | 17.77M | -27.39% |
Net income | -16.80M | 24.89% |
Net profit margin | -4.14K | 14.53% |
Earnings per share | -6.72 | 27.74% |
EBITDA | -17.01M | 28.17% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 114.10M | -40.28% |
Total assets | 186.55M | -34.43% |
Total liabilities | 63.30M | -25.96% |
Total equity | 123.25M | — |
Shares outstanding | 2.51M | — |
Price to book | 0.41 | — |
Return on assets | -22.22% | — |
Return on capital | -23.03% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -16.80M | 24.89% |
Cash from operations | -19.79M | -17.69% |
Cash from investing | 42.29M | 271.21% |
Cash from financing | 0.00 | — |
Net change in cash | 22.51M | 154.21% |
Free cash flow | -6.99M | 34.92% |
Previous close
$20.01
Year range
$5.34 - $23.30
Market cap
50.70M USD
Avg Volume
7.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2016
Website
Employees
255
